Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points

Background: The correlation between efficacy end points in randomized controlled trials (RCTs) of systemic therapy for non-Hodgkin's lymphoma (NHL) was investigated to identify an appropriate surrogate end point for overall survival (OS). Methods: RCTs of previously untreated NHL published from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, L., Wang, L., Crump, M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101365/
https://www.ncbi.nlm.nih.gov/pubmed/21266519
http://dx.doi.org/10.1093/annonc/mdq615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101365/
https://www.ncbi.nlm.nih.gov/pubmed/21266519
http://dx.doi.org/10.1093/annonc/mdq615

Ejemplares similares